Literature DB >> 6210844

Sister-chromatid exchange (SCE) analysis in mothers exposed to DNA-damaging agents and their newborn infants.

R Seshadri, E Baker, G R Sutherland.   

Abstract

The incidence of SCE in the lymphocytes of mothers and their newborn infants was determined. A detailed antenatal history of parental habits such as smoking, alcohol consumption and possible exposure to DNA-damaging agents was documented. The results showed that the SCE rate in the newborn is significantly less than that of their mothers. Mothers who consumed alcohol, but not cigarette smokers, had a significantly increased SCE rate compared to control mothers. However, these maternal habits did not affect the SCE rate of their infants. Neonates with neural tube defects showed a significantly increased SCE rate compared to normal babies.

Entities:  

Mesh:

Year:  1982        PMID: 6210844     DOI: 10.1016/0165-1161(82)90011-5

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  Sister chromatid exchanges in lymphocytes of normal and alcoholic subjects.

Authors:  J R Lazutka; V Dedonyte; R K Lekevicius
Journal:  Experientia       Date:  1992-05-15

2.  [On the induction of sister chromatid exchange by diethylstilbestrol and mitomycin C in lymphocytes of mothers and their newborn infants].

Authors:  X M Che; B Schmidt; H Dunkelberg; J Borneff
Journal:  J Tongji Med Univ       Date:  1987

3.  Cytogenetic effects of methyl isocyanate exposure in Bhopal.

Authors:  H K Goswami
Journal:  Hum Genet       Date:  1986-09       Impact factor: 4.132

4.  Analysis of sister chromatid exchanges in lymphocytes cultured from 71 healthy men.

Authors:  A K Sinha; V A Linscombe; B B Gollapudi; G C Jersey; C N Park
Journal:  Cell Biol Toxicol       Date:  1985-10       Impact factor: 6.691

Review 5.  A review of approaches to the detection of genetic damage in the human fetus.

Authors:  R B Everson
Journal:  Environ Health Perspect       Date:  1987-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.